Page 1 | Search Results | The Hematologist | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Articles

Point-Counterpoint Chimeric Antigen Receptor T Cells: The Preferred Second-line Therapy for Relapsed/Refractory Large B-cell Lymphomas

Jeremy S. Abramson, MD

The Hematologist (2024) 21 (4)

https://doi.org/10.1182/hem.V21.4.202441

Published: 2024